AZIYO BIOLOGICS, INC. (AZYO) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Net income	-10.6	-8.0	-5.4	-9.9	-9.4	-8.1	-9.1	-8.3
Depreciation and amortization	1.0	0.9	0.9	0.9	0.9	0.9	0.9	0.9
Stock-based compensation	0.7	0.7	0.8	0.3	1.5	1.1	1.0	1.0
Change in working capital [+]	4.1	2.4	2.8	-14.7	2.5	-2.4	0.7	2.2
Accounts receivable	0.2	-0.5	0.3	-0.5	-0.6	0.0	-0.5	2.2
Inventories	-0.2	-1.0	0.1	-0.5	0.2	-0.3	0.3	0.5
Other current assets	0.0	0.6	-2.0	0.8	1.2	-1.6	-0.2	0.5
Other	4.2	3.3	4.3	-14.5	1.8	-0.5	1.0	-1.1
Other operating activities	2.5	-1.2	-4.3	17.9	1.1	1.2	0.1	1.1
Cash from operations	-2.4	-5.2	-5.2	-5.5	-3.3	-7.4	-6.4	-3.1

Capital expenditures	-0.1	-0.2	-0.1	-0.1	-0.3	0.0	0.0	-0.1
Purchases of property and equipment	-0.1	-0.2	-0.1	-0.1	-0.3	0.0	0.0	-0.1
Cash from investing	-0.1	-0.2	-0.1	-0.1	-0.3	0.0	0.0	-0.1

Issuance of common stock, net			10.2			-0.1	13.8
Option exercises		0.1	0.1	0.1		0.2		0.2
Financing costs				-0.5
Other cash from financing	0.0	0.3	4.1	-3.1	-2.1	-0.6	0.5	-2.3
Cash from financing	0.0	0.1	14.3	-2.8	-2.1	-0.9	14.2	-2.5

Free cash flow	-2.5	-5.3	-5.4	-5.6	-3.6	-7.4	-6.4	-3.2
Per share (diluted)	($0.15)	($0.33)	($0.39)	($0.41)	($0.26)	($0.54)	($0.61)	($0.31)

Cash paid for interest	0.5	0.6	0.4	3.9		1.2	1.2	1.3